#Antihyperglycemics
Itching for more diabetes #deprescribing resources?

Find more helpful tools for deprescribing antihyperglycemics here at:
buff.ly/48I6Ph9

Also learn about our study to Deintensifying Diabetes Management for Older Adults Living in LTC (DIAL) here:
buff.ly/4gIHzeK
Deprescribing Guidelines and Algorithms - Deprescribing.org
buff.ly
February 23, 2025 at 9:01 PM
sulfonylureas (n = 159,465)
dipeptidyl peptidase 4 (DPP4) inhibitors (n = 117,989)

Controls composed of initiating sulfonylureas, DPP4 inhibitors and SGLT2 inhibitors (n = 536,068), or who continued the use of non-GLP-1RA antihyperglycemics (usual care n=1,203,097).
3/5
January 21, 2025 at 5:56 PM
Reduction of HCC risk with GLP-1RA in diabetics? Comparisons between the GLP-1RA use group (n = 215,970) and the usual care group who continued use of non-GLP-1RA antihyperglycemics (n = 1,203,097), from the VA database. Risk reduction 18%.
shorturl.at/cl2Nc
March 13, 2025 at 3:57 PM
Alexa’s research focuses on optimizing the use of statins and antihyperglycemics for older adults living in long-term care, by co-designing, refining, and implementing tools with long-term care staff, clinicians, and residents and caregivers.

@pharmacy.utoronto.ca
May 28, 2026 at 4:04 PM
Agreed. Although a biochemist with type 2 diabetes, I don't use the GLP-1 agonists or SGLT2 inhibitors. At one point my BMI was well within normal and I was able to get off any antihyperglycemics (glipizide, metformin)

Biomedical research to help fight chronic inflammatory conditions must be pushed
December 31, 2025 at 5:10 PM
Struggling with your oral antihyperglycemic drugs assignment? This step-by-step guide simplifies the topic.
#NursingSchool #PharmacologyMadeEasy #Antihyperglycemics #StudyTips #NursingStudents #PharmaGuide #MedicalSchoolHelp #KenyaNurses #PassYourAssignment #FutureNurse
August 4, 2025 at 5:31 PM